Solid Biosciences Inc. (SLDB) income statement
SLDBNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$6.25−0.19 (-2.95%)
Close on Nov 20, 2026Market cap $670.16MP/E –Yield –
Solid Biosciences Inc. financial ratios
See a number that looks wrong?